Literature DB >> 26639024

A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction.

Arman Rahmim1, C Ross Schmidtlein, Andrew Jackson, Sara Sheikhbahaei, Charles Marcus, Saeed Ashrafinia, Madjid Soltani, Rathan M Subramaniam.   

Abstract

Oncologic PET images provide valuable information that can enable enhanced prognosis of disease. Nonetheless, such information is simplified significantly in routine clinical assessment to meet workflow constraints. Examples of typical FDG PET metrics include: (i) SUVmax, (2) total lesion glycolysis (TLG), and (3) metabolic tumor volume (MTV). We have derived and implemented a novel metric for tumor quantification, inspired in essence by a model of generalized equivalent uniform dose as used in radiation therapy. The proposed metric, denoted generalized effective total uptake (gETU), is attractive as it encompasses the abovementioned commonly invoked metrics, and generalizes them, for both homogeneous and heterogeneous tumors, using a single parameter a. We evaluated this new metric for improved overall survival (OS) prediction on two different baseline FDG PET/CT datasets: (a) 113 patients with squamous cell cancer of the oropharynx, and (b) 72 patients with locally advanced pancreatic adenocarcinoma. Kaplan-Meier survival analysis was performed, where the subjects were subdivided into two groups using the median threshold, from which the hazard ratios (HR) were computed in Cox proportional hazards regression. For the oropharyngeal cancer dataset, MTV, TLG, SUVmax, SUVmean and SUVpeak produced HR values of 1.86, 3.02, 1.34, 1.36 and 1.62, while the proposed gETU metric for a  = 0.25 (greater emphasis on volume information) enabled significantly enhanced OS prediction with HR  =  3.94. For the pancreatic cancer dataset, MTV, TLG, SUVmax, SUVmean and SUVpeak resulted in HR values of 1.05, 1.25, 1.42, 1.45 and 1.52, while gETU at a  = 3.2 (greater emphasis on SUV information) arrived at an improved HR value of 1.61. Overall, the proposed methodology allows placement of differing degrees of emphasis on tumor volume versus uptake for different types of tumors to enable enhanced clinical outcome prediction.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26639024      PMCID: PMC4887091          DOI: 10.1088/0031-9155/61/1/227

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  57 in total

1.  A novel fuzzy C-means algorithm for unsupervised heterogeneous tumor quantification in PET.

Authors:  Saoussen Belhassen; Habib Zaidi
Journal:  Med Phys       Date:  2010-03       Impact factor: 4.071

2.  Prognostic significance of 18F-FDG PET parameters and plasma Epstein-Barr virus DNA load in patients with nasopharyngeal carcinoma.

Authors:  Kai-Ping Chang; Ngan-Ming Tsang; Chun-Ta Liao; Cheng-Lung Hsu; Ming-Jui Chung; Chuan-Wei Lo; Sheng-Chieh Chan; Shu-Hang Ng; Hung-Ming Wang; Tzu-Chen Yen
Journal:  J Nucl Med       Date:  2012-01       Impact factor: 10.057

Review 3.  Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development.

Authors:  Gary J Kelloff; John M Hoffman; Bruce Johnson; Howard I Scher; Barry A Siegel; Edward Y Cheng; Bruce D Cheson; Joyce O'shaughnessy; Kathryn Z Guyton; David A Mankoff; Lalitha Shankar; Steven M Larson; Caroline C Sigman; Richard L Schilsky; Daniel C Sullivan
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

4.  18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort.

Authors:  Mathieu Hatt; Mohamed Majdoub; Martin Vallières; Florent Tixier; Catherine Cheze Le Rest; David Groheux; Elif Hindié; Antoine Martineau; Olivier Pradier; Roland Hustinx; Remy Perdrisot; Remy Guillevin; Issam El Naqa; Dimitris Visvikis
Journal:  J Nucl Med       Date:  2014-12-11       Impact factor: 10.057

Review 5.  Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyond.

Authors:  David A Mankoff; Janet F Eary; Jeanne M Link; Mark Muzi; Joseph G Rajendran; Alexander M Spence; Kenneth A Krohn
Journal:  Clin Cancer Res       Date:  2007-06-15       Impact factor: 12.531

6.  Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

Authors:  Steven M. Larson; Yusuf Erdi; Timothy Akhurst; Madhu Mazumdar; Homer A. Macapinlac; Ronald D. Finn; Cecille Casilla; Melissa Fazzari; Neil Srivastava; Henry W.D. Yeung; John L. Humm; Jose Guillem; Robert Downey; Martin Karpeh; Alfred E. Cohen; Robert Ginsberg
Journal:  Clin Positron Imaging       Date:  1999-05

7.  Comparative assessment of methods for estimating tumor volume and standardized uptake value in (18)F-FDG PET.

Authors:  Perrine Tylski; Simon Stute; Nicolas Grotus; Kaya Doyeux; Sébastien Hapdey; Isabelle Gardin; Bruno Vanderlinden; Irène Buvat
Journal:  J Nucl Med       Date:  2010-01-15       Impact factor: 10.057

8.  Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy.

Authors:  Jacques-Antoine Maisonobe; Camilo A Garcia; Hatem Necib; Bruno Vanderlinden; Alain Hendlisz; Patrick Flamen; Irène Buvat
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-14       Impact factor: 9.236

Review 9.  Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states.

Authors:  Sandip Basu; Habib Zaidi; Mohamed Houseni; Gonca Bural; Jay Udupa; Paul Acton; Drew A Torigian; Abass Alavi
Journal:  Semin Nucl Med       Date:  2007-05       Impact factor: 4.446

10.  From patient-specific mathematical neuro-oncology to precision medicine.

Authors:  A L Baldock; R C Rockne; A D Boone; M L Neal; A Hawkins-Daarud; D M Corwin; C A Bridge; L A Guyman; A D Trister; M M Mrugala; J K Rockhill; K R Swanson
Journal:  Front Oncol       Date:  2013-04-02       Impact factor: 6.244

View more
  9 in total

1.  Radiomics Analysis of PET and CT Components of PET/CT Imaging Integrated with Clinical Parameters: Application to Prognosis for Nasopharyngeal Carcinoma.

Authors:  Wenbing Lv; Qingyu Yuan; Quanshi Wang; Jianhua Ma; Qianjin Feng; Wufan Chen; Arman Rahmim; Lijun Lu
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

2.  Robustness of Radiomic Features in [11C]Choline and [18F]FDG PET/CT Imaging of Nasopharyngeal Carcinoma: Impact of Segmentation and Discretization.

Authors:  Lijun Lu; Wenbing Lv; Jun Jiang; Jianhua Ma; Qianjin Feng; Arman Rahmim; Wufan Chen
Journal:  Mol Imaging Biol       Date:  2016-12       Impact factor: 3.488

3.  A Novel Framework for Automated Segmentation and Labeling of Homogeneous Versus Heterogeneous Lung Tumors in [18F]FDG-PET Imaging.

Authors:  Motahare Soufi; Alireza Kamali-Asl; Parham Geramifar; Arman Rahmim
Journal:  Mol Imaging Biol       Date:  2017-06       Impact factor: 3.488

Review 4.  Applications and limitations of radiomics.

Authors:  Stephen S F Yip; Hugo J W L Aerts
Journal:  Phys Med Biol       Date:  2016-06-08       Impact factor: 3.609

5.  Subregional Radiomics Analysis of PET/CT Imaging with Intratumor Partitioning: Application to Prognosis for Nasopharyngeal Carcinoma.

Authors:  Hui Xu; Wenbing Lv; Hui Feng; Dongyang Du; Qingyu Yuan; Quanshi Wang; Zhenhui Dai; Wei Yang; Qianjin Feng; Jianhua Ma; Lijun Lu
Journal:  Mol Imaging Biol       Date:  2020-10       Impact factor: 3.488

6.  Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments.

Authors:  Arman Rahmim; Yousef Salimpour; Saurabh Jain; Stephan A L Blinder; Ivan S Klyuzhin; Gwenn S Smith; Zoltan Mari; Vesna Sossi
Journal:  Neuroimage Clin       Date:  2016-02-23       Impact factor: 4.881

7.  Multitask Learning Radiomics on Longitudinal Imaging to Predict Survival Outcomes following Risk-Adaptive Chemoradiation for Non-Small Cell Lung Cancer.

Authors:  Parisa Forouzannezhad; Dominic Maes; Daniel S Hippe; Phawis Thammasorn; Reza Iranzad; Jie Han; Chunyan Duan; Xiao Liu; Shouyi Wang; W Art Chaovalitwongse; Jing Zeng; Stephen R Bowen
Journal:  Cancers (Basel)       Date:  2022-02-26       Impact factor: 6.575

8.  Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer.

Authors:  Martin Vallières; Emily Kay-Rivest; Léo Jean Perrin; Xavier Liem; Christophe Furstoss; Hugo J W L Aerts; Nader Khaouam; Phuc Felix Nguyen-Tan; Chang-Shu Wang; Khalil Sultanem; Jan Seuntjens; Issam El Naqa
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

9.  Improved prediction of outcome in Parkinson's disease using radiomics analysis of longitudinal DAT SPECT images.

Authors:  Arman Rahmim; Peng Huang; Nikolay Shenkov; Sima Fotouhi; Esmaeil Davoodi-Bojd; Lijun Lu; Zoltan Mari; Hamid Soltanian-Zadeh; Vesna Sossi
Journal:  Neuroimage Clin       Date:  2017-08-26       Impact factor: 4.881

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.